Cargando…

Bis(μ-4,4;6,6-bis­(biphenyl-2,2′-diyldi­oxy)-2,2-bis­{2-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]phen­oxy}cyclo­triphosphazene)di-μ-chlorido-bis­[chlorido­copper(II)]

In the crystal of the title compound, [Cu(2)Cl(4)(C(50)H(32)N(9)O(8)P(3))(2)], the binuclear mol­ecule is located across an inversion center. Each Cu(2+) cation is coordinated by two pyridine N atoms from symmetry-related 4,4;6,6-bis­(biphenyl-2,2′-diyldi­oxy)-2,2-bis­{2-[5-(pyridin-4-yl)-1,3,4-oxad...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiang-Wen, Wang, Xiao-Yan, Ma, Jian-Ping, Dong, Yu-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344371/
https://www.ncbi.nlm.nih.gov/pubmed/22590137
http://dx.doi.org/10.1107/S1600536812016285
_version_ 1782231977538093056
author Wu, Xiang-Wen
Wang, Xiao-Yan
Ma, Jian-Ping
Dong, Yu-Bin
author_facet Wu, Xiang-Wen
Wang, Xiao-Yan
Ma, Jian-Ping
Dong, Yu-Bin
author_sort Wu, Xiang-Wen
collection PubMed
description In the crystal of the title compound, [Cu(2)Cl(4)(C(50)H(32)N(9)O(8)P(3))(2)], the binuclear mol­ecule is located across an inversion center. Each Cu(2+) cation is coordinated by two pyridine N atoms from symmetry-related 4,4;6,6-bis­(biphenyl-2,2′-diyldi­oxy)-2,2-bis­{2-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]phen­oxy}cyclo­triphosphazene (L) ligands, a pair of bridging Cl(−) anions and a terminal Cl(−) anion, forming a distorted CuCl(3)N(2) square-pyramidal geometry. Weak intra­molecular C—H⋯O and inter­molecular C—H⋯N inter­actions occur in the crystal.
format Online
Article
Text
id pubmed-3344371
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-33443712012-05-15 Bis(μ-4,4;6,6-bis­(biphenyl-2,2′-diyldi­oxy)-2,2-bis­{2-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]phen­oxy}cyclo­triphosphazene)di-μ-chlorido-bis­[chlorido­copper(II)] Wu, Xiang-Wen Wang, Xiao-Yan Ma, Jian-Ping Dong, Yu-Bin Acta Crystallogr Sect E Struct Rep Online Metal-Organic Papers In the crystal of the title compound, [Cu(2)Cl(4)(C(50)H(32)N(9)O(8)P(3))(2)], the binuclear mol­ecule is located across an inversion center. Each Cu(2+) cation is coordinated by two pyridine N atoms from symmetry-related 4,4;6,6-bis­(biphenyl-2,2′-diyldi­oxy)-2,2-bis­{2-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]phen­oxy}cyclo­triphosphazene (L) ligands, a pair of bridging Cl(−) anions and a terminal Cl(−) anion, forming a distorted CuCl(3)N(2) square-pyramidal geometry. Weak intra­molecular C—H⋯O and inter­molecular C—H⋯N inter­actions occur in the crystal. International Union of Crystallography 2012-04-21 /pmc/articles/PMC3344371/ /pubmed/22590137 http://dx.doi.org/10.1107/S1600536812016285 Text en © Wu et al. 2012 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Metal-Organic Papers
Wu, Xiang-Wen
Wang, Xiao-Yan
Ma, Jian-Ping
Dong, Yu-Bin
Bis(μ-4,4;6,6-bis­(biphenyl-2,2′-diyldi­oxy)-2,2-bis­{2-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]phen­oxy}cyclo­triphosphazene)di-μ-chlorido-bis­[chlorido­copper(II)]
title Bis(μ-4,4;6,6-bis­(biphenyl-2,2′-diyldi­oxy)-2,2-bis­{2-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]phen­oxy}cyclo­triphosphazene)di-μ-chlorido-bis­[chlorido­copper(II)]
title_full Bis(μ-4,4;6,6-bis­(biphenyl-2,2′-diyldi­oxy)-2,2-bis­{2-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]phen­oxy}cyclo­triphosphazene)di-μ-chlorido-bis­[chlorido­copper(II)]
title_fullStr Bis(μ-4,4;6,6-bis­(biphenyl-2,2′-diyldi­oxy)-2,2-bis­{2-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]phen­oxy}cyclo­triphosphazene)di-μ-chlorido-bis­[chlorido­copper(II)]
title_full_unstemmed Bis(μ-4,4;6,6-bis­(biphenyl-2,2′-diyldi­oxy)-2,2-bis­{2-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]phen­oxy}cyclo­triphosphazene)di-μ-chlorido-bis­[chlorido­copper(II)]
title_short Bis(μ-4,4;6,6-bis­(biphenyl-2,2′-diyldi­oxy)-2,2-bis­{2-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]phen­oxy}cyclo­triphosphazene)di-μ-chlorido-bis­[chlorido­copper(II)]
title_sort bis(μ-4,4;6,6-bis­(biphenyl-2,2′-diyldi­oxy)-2,2-bis­{2-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]phen­oxy}cyclo­triphosphazene)di-μ-chlorido-bis­[chlorido­copper(ii)]
topic Metal-Organic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344371/
https://www.ncbi.nlm.nih.gov/pubmed/22590137
http://dx.doi.org/10.1107/S1600536812016285
work_keys_str_mv AT wuxiangwen bism4466bisbiphenyl22diyldioxy22bis25pyridin4yl134oxadiazol2ylphenoxycyclotriphosphazenedimchloridobischloridocopperii
AT wangxiaoyan bism4466bisbiphenyl22diyldioxy22bis25pyridin4yl134oxadiazol2ylphenoxycyclotriphosphazenedimchloridobischloridocopperii
AT majianping bism4466bisbiphenyl22diyldioxy22bis25pyridin4yl134oxadiazol2ylphenoxycyclotriphosphazenedimchloridobischloridocopperii
AT dongyubin bism4466bisbiphenyl22diyldioxy22bis25pyridin4yl134oxadiazol2ylphenoxycyclotriphosphazenedimchloridobischloridocopperii